Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 19, 2019 - Issue 8
Submit an article Journal homepage
862
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Emicizumab for the prevention of bleeds in hemophilia A

Johnny MahlanguHaematology, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence[email protected]
View further author information
Pages 753-761 | Received 02 Jan 2019, Accepted 29 May 2019, Published online: 13 Jun 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Johnny Mahlangu. (2022) An update of the current pharmacotherapeutic armamentarium for hemophilia A. Expert Opinion on Pharmacotherapy 23:1, pages 129-138.
Read now

Articles from other publishers (6)

Jacqueline Poston & Rebecca Kruse-Jarres. (2023) The role of emicizumab in acquired hemophilia A. Hematology 2023:1, pages 24-30.
Crossref
Jacob Lund, Kasper Jensen, Laurent Burnier & Mirella Ezban. (2023) In vitro effects of combining Mim8 with factor VIII, FVIIa, and activated prothrombin complex concentrates in thrombin generation assays. Journal of Thrombosis and Haemostasis 21:6, pages 1493-1502.
Crossref
Giovanni Di Minno, Giancarlo Castaman, Raimondo De Cristofaro, Nicola Brunetti-Pierri, Lucio Pastore, Giuseppe Castaldo, Ugo Trama & Matteo Di Minno. (2023) Progress, and prospects in the therapeutic armamentarium of persons with congenital hemophilia. Defining the place for liver-directed gene therapy. Blood Reviews 58, pages 101011.
Crossref
Michael A. Nardi. 2023. 273 315 .
Gaia Spadarella, Alessandro Di Minno, Nicola Brunetti-Pierri, Johnny Mahlangu & Giovanni Di Minno. (2021) The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies. Blood Reviews 46, pages 100737.
Crossref
Cedric Hermans & Catherine Lambert. (2020) Impact of the COVID‐19 pandemic on therapeutic choices in thrombosis‐hemostasis. Journal of Thrombosis and Haemostasis 18:7, pages 1794-1795.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.